ALXN
Alexion Pharmaceuticals, Inc.
EVP and Chief Compliance Officer Indrani Lall Franchini sold $170K of Alexion Pharmaceuticals, Inc.
Sold$169,696
$116.31Price
1,459Shares
−6%Stake
What ALXN did after the filing
Prices for ALXN after this filing aren't in yet.
Traded Thu, Feb 8. Filed Thu, Feb 8, 2:16 PM ET, during the session. Not investment advice.